clinical stage biopharma

Veradermics Closes Full IPO Share Option Exercise

NEW HAVEN, Conn., Feb. 5, 2026 — Veradermics, Incorporated, a late clinical-stage biopharmaceutical company focused on dermatology therapeutics, announced...

By cGxPwire Editor
February 6, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

clinical stage biopharma

Veradermics Closes Full IPO Share Option Exercise